| Balance Sheets | 2026-06-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 1,087,060 | |||
| Marketable securities | 33,637 | |||
| Prepaid expenses and other current assets | 4,699 | |||
| Total current assets | 1,125,396 | |||
| Property and equipment, net | 6,718 | |||
| Restricted cash | 2,855 | |||
| Operating lease right-of-use assets | 36,007 | |||
| Other assets | 4,286 | |||
| Total assets | 1,175,262 | |||
| Accounts payable | 18,525 | |||
| Accrued expenses and other current liabilities | 19,972 | |||
| Operating lease liabilities, current portion | 7,592 | |||
| Deferred revenue, current portion | 10,371 | |||
| Finance lease liabilities, current portion | 669 | |||
| Term loan, net of discount | 5,710 | |||
| Total current liabilities | 62,839 | |||
| Operating lease liabilities, net of current portion | 32,413 | |||
| Finance lease liabilities, net of current portion | 1,128 | |||
| Deferred revenue, net of current portion | 31,148 | |||
| Other liabilities | 0 | |||
| Total liabilities | 127,528 | |||
| Convertible preferred stock | 0 | |||
| Preferred stock | 0 | |||
| Common stock | 12 | |||
| Non-voting common stock, value | 0 | |||
| Additional paid in capital | 1,687,023 | |||
| Accumulated other comprehensive loss | -18 | |||
| Accumulated deficit | -639,283 | |||
| Total stockholders' equity (deficit) | 1,047,734 | |||
| Total liabilities, convertible preferred stock and stockolders ' equity (deficit) | 1,175,262 | |||
Parabilis Medicines, Inc. (PBLS)
Parabilis Medicines, Inc. (PBLS)